CTOs on the Move

480 Biomedical

www.480biomedical.com

 
480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

480 Biomedical raised $10M on 06/01/2015

Similar Companies

Reverie Labs

Engineering next‑generation, brain‑penetrant cancer therapies.

Priovant Therapeutics

Priovant Therapeutics is a clinical stage biotechnology company developing targeted therapies for patients with severe autoimmune disease.

Millennium Pharmaceuticals Inc

Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering

Caprion Proteomics

Caprion Proteomics Inc. is a Gatineau, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chromotrax

Chromotrax is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.